SYS-CON MEDIA Authors: Michael Bushong, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

2013 Report on the International Epigenetics Drugs and Diagnostic Technologies Market - Trends And Forecasts to 2018

DUBLIN, January 27, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/g3pk2m/epigenetics_drugs) has announced the addition of the "2013 Report on the International Epigenetics Drugs and Diagnostic Technologies Market - Trends And Forecasts to 2018" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

"2013 Report on the International Epigenetics Drugs and Diagnostic Technologies Market - Trends And Forecasts to 2018", on the epigenetics drugs and diagnostic technologies market provides detailed analysis of the global market and helps in understanding the driving forces for the growth of these technologies. The report also provides analysis of the drugs market by the mechanism of its action namely, DNMT inhibitors and HDAC inhibitors. 

The report also discusses the diagnostic technologies market by types which include DNA methylation and ChIP (Chromatin Immunoprecipitation) technology. Market size estimates and forecasts for the period 2010 to 2018 has been given for each segment and sub-segment, in terms of USD million, using 2010 as the base year. The market has also been segmented geographically into four regions namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). Market size and forecast has been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the epigenetics market and future opportunities are provided in the report. 

Competitive landscape and end user analysis for the product types is highlighted and the market players are profiled with attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. 

The global epigenetics drugs and diagnostic technologies market is segmented into the following categories:

  • Epigenetics Drugs Market, by Mechanism of Action
  • DNMT Inhibitors
  • Azacitidine (Vidaza)
  • Decitabine (Dacogen
  • HDAC Inhibitors
  • Vorinostat (Zolinza
  • Romidepsin (Istodax)
  • Epigenetics Diagnostic Technologies Market, by Types
  • DNA Methylation
  • Chromatin Immunoprecipitation (ChIP) Technology


Key Topics Covered: 

1 Preface

2 Executive Summary

3 Market Overview

4 Epigenetics Drugs Market, By Mechanism Of Action

5 Epigenetics Diagnostic Technology Market, By Types

6 Global Epigenetics Technologies Market, By Geography

7 Competitive Landscape

8 Recommendations

9 Company Profiles



Companies Mentioned:

  • 4SC
  • Acetylon Pharmaceuticals
  • Astex Pharmaceuticals
  • Celgene Corporation
  • Cellcentric
  • Celleron Therapeutics
  • Chroma Therapeutics
  • Eisai
  • Envivo Pharmaceuticals
  • Epigentek Group
  • Epizyme
  • Illumina
  • Mdxhealth
  • Merck & Company
  • Novartis International
  • Oncolys Biopharma
  • Pharmacyclics
  • Repligen Corporation
  • Spectrum Pharmaceuticals
  • Syndax Pharmaceuticals
  • Topotarge
  • Valirx



For more information visit http://www.researchandmarkets.com/research/g3pk2m/epigenetics_drugs


Media Contact: Laura Wood , +353-1-481-1716, [email protected]


More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.